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A kinase activity that phosphorylated myelin basic protein in vitro was detected in RalA and RalB immunoprecipitates from human platelets.
Protein–protein interaction studies using recombinant GST-RalA, GST-RalB and GST-cH-Ras confirmed that the kinase specifically associates
with the Ral GTPase. The Ral Interacting Protein 1 (RIP1), a GTPase Activating Protein (GAP) for Cdc42 and Rac1, was found to be the preferred
substrate for the Ral Interacting Kinase (RIK). Phosphoamino acid analysis demonstrated that RIK phosphorylated serine residue in RIP1. The
Ral–RIK interaction was not dependent on the guanine nucleotide status of Ral. RIK was detected in a variety of rat tissues with testis containing
the highest and skeletal muscle the lowest activity. In-gel kinase renaturation assay using RIP1 as the substrate demonstrated that the kinase
activity was associated with polypeptides of molecular mass of ∼36–40 kDa and was detected in most rat tissues with a prominent 38 kDa band in
testis and a 40 kDa band in brain. Human platelets contained a single band of ∼36 kDa. RIK was distinct from MAPKs, CDKs, cyclic AMP
dependent protein kinase and Ca2+/calmodulin dependent kinases. To demonstrate in vivo interaction, the endogenous Ral–RIK complex was
isolated using a calmodulin affinity column. The Ral–RIK complex co-eluted from this column upon washing with a 13 residue peptide that
encompasses the calmodulin-binding domain in RalA. The data suggest that RIK is a serine specific kinase that phosphorylates RIP1 and is
constitutively associated with Ral. The current study provides additional support for a link between Ral and the Cdc42/Rac1 signalling pathways
in the cell.
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The Ral proteins, RalA and RalB, are ∼85% identical and
belong to the Ras superfamily of low molecular weight GTP-
binding proteins [1]. Northern and Western blot analysis has
demonstrated that RalA and RalB are ubiquitously expressed
in mouse and rat tissues with testis, ovaries, brain and platelets
containing the highest level [2,3]. The subcellular distribution
analysis has demonstrated the association of Ral with the vitro
plasma membrane [4], synaptic and axonal rapid transport
vesicles [5,6], and platelet dense granules [7]. In platelets,
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fraction [8]. The Ral proteins function as molecular switches
and cycle between a GTP-bound active and a GDP-bound
inactive state [1]. Ral has been implicated in a variety of
cellular functions including, proliferation [9], migration [10],
filopod formation [11], differentiation [12], cytoskeletal
organization [13], vesicular transport [14], exocytosis [15],
and receptor endocytosis [16,17].
As is the case for other signalling molecules, a role for Ral
in various cellular pathways has been established initially
through the identification of proteins that interact with this
GTPase. Thus, Ral Binding Protein 1 (RIP1 or RLIP76)
interacts with the GTP-bound form of Ral and RIP1 acts as a
GAP (GTPase activating protein) for Cdc42 and Rac1, two
GTPases involved in cytoskeletal organization [18,19]. Ral
has also been shown to associate constitutively with
phospholipase D [20] and interact with filamin-α, an actin
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interacts specifically with the Sec5p protein in the exocyst
complex [14], a group of eight proteins originally identified in
yeast as necessary for the secretory process [22]. Recent
studies have demonstrated that the calcium binding protein,
calmodulin, interacts with Ral in vitro [23,24] and in vivo
[24]. Furthermore, calmodulin was found to be necessary for
the thrombin mediated activation of Ral in platelets [24]. More
recently we have shown that Ral interacts with PLC-δ1 and
that this interaction results in the stimulation of the activity of
this enzyme [25].
In order to identify new signalling pathways that require
Ral participation, we have been attempting to characterize
additional cellular proteins that interact with Ral. In the
present study we have used in vitro pull-down assays and
immunoprecipitation to demonstrate interaction between a
protein kinase and Ral. The kinase termed, RIK (for Ral
Interacting Kinase), is an ∼36–40 kDa serine kinase that
specifically associates with Ral and phosphorylates RIP1, a
downstream effector of Ral.
2. Materials and methods
2.1. Reagents and plasmids
pGEX-4T-3 E. coli expression vector, restriction enzymes and various
molecular biology reagents were from Amersham Biosciences. Total histones,
casein, myelin basic protein (MBP), 3-[(3-chloramidopropyl)dimethyl-ammo-
nio]-1-propanesulfonate (CHAPS), 2-[N-Morpholino]ethanesulfonic acid
(MES), rabbit IgG, protein A-Sepharose, glutathione-agarose beads, calmodu-
lin-agarose beads, standard protein solution, GDP and GTP were purchased
from Sigma. [α-32P]GTP (3700 Ci/mmol) and [γ-32P]ATP (4500 Ci/mmol) were
obtained from ICN Radiochemicals. PVDF membrane, Triton-X-100, protein-
dye reagent, prestained protein markers and nitrocellulose membrane (0.2 μm)
were obtained from Bio-Rad Laboratories. GST-Rb (a.a. 769–921) fusion
protein containing the phosphorylation site for cyclin dependent kinase was
purchased from Santa Cruz Biotechnology Inc. GST-RIP1 construct was kindly
provided by Dr. A. Weinberg (Massachusetts Institute of Technology,
Cambridge, MA, USA). GST-c-Jun (a.a. 1–79), GST-ATF2 (a.a. 1–109) and
GST-p38MAPK E. coli expression plasmids were supplied by Dr. R. J. Davis
(University of Massachusetts, Worcester, MA, USA). cDNA coding for the
RalAVal23 mutant (constitutively active form) was obtained from Dr. P. Chardin
(INSERM, Valbonne, France). All other reagents were of analytical grade.
2.2. Glutathione-S-transferase (GST)-fusion protein expression and
purification
Details of subcloning and expression of GST-RalA, GST-RalB, GST-cH-Ras
and RIP1 Ral binding domain (GST-RRBD) recombinant proteins in E. coli was
previously described [8,24]. To express GST-RalAVal23, refilled HinDIII–
EcoRI fragment containing the RalAVal23 gene was inserted into the pGEX-4T-3
plasmid digested with SmaI and EcoRI. Various GST-fusion proteins used in the
current study were purified by affinity chromatography using glutathione
agarose beads as previously described [8]. The beads were resuspended at a 1:1
ratio in storage buffer (20 mM Tris–HCl, pH 8.0, and 100 mMNaCl) and kept at
4 °C until further use. Typically, the recovery was∼2 μg of recombinant protein/
μl of bead suspension. The purified recombinant protein was homogenous as
judged by SDS-PAGE.
2.3. Loading of recombinant RalAVal23 with GDP or GTP
Recombinant GST-RalAVal23 bound to glutathione-agarose beads was
loaded with GDP or GTP by adding 1 vol of exchange buffer (25 mM MES-NaOH, pH 6.5, 50 mM NaCl, 2.5 mM EDTA, 0.05% Triton X-100 and
0.5 mM GDP or GTP). After 5 min incubation at room temperature, the
beads were washed with 1 ml of cold buffer containing, 10 mM Na-
phosphate, pH 6.8, 20 mM MgCl2 and 0.5 mM GDP or GTP, and kept at
4 °C until required. To confirm that RalA was loaded with GTP, we used the
Ral interacting domain from Ral-interacting protein 1 (RRBD) [24]. Briefly,
GTP or GDP loaded RalA were recovered in the supernatant after cleavage of
the GST tag from the recombinant protein using thrombin [8]. The RalA-GTP
or RalA-GDP was incubated with GSH-agarose beads coated with GST-
RRBD [24]. The amount of RalA bound to these beads was assessed by SDS-
PAGE and western blotting using a monoclonal antibody against RalA (BD
Biosciences).
2.4. Platelet and rat tissue extract preparation
Human platelets obtained from the local Red Cross were washed twice in
phosphate buffered saline and lysed in buffer A (10 mM Na-phosphate, pH 6.8,
1 mM DTT, 1 mM EDTA and 0.5% CHAPS). After centrifugation at
100,000×g for 1 h at 4 °C the supernatant was collected. To avoid actin
polymerisation, the platelet extract was used immediately for immunoprecipita-
tion and for interaction experiments. For studies on tissue distribution, rat
tissues were homogenised in a blender in buffer A. After centrifugation at
100,000×g for 1 h at 4 °C the supernatant was collected and kept on ice until
further use.
2.5. Immunoprecipitation of RalA and RalB
1 ml of platelet extract (∼10 mg protein/ml) was incubated with 1–5 μg of
RalA, RalB antibodies [8] or non-specific rabbit IgG for 1 h at 4 °C. 50 μl of
protein A-Sepharose bead suspension was added and the incubation continued
for an additional 30 min at 4 °C. The beads were collected by centrifugation,
washed 3 times in buffer containing, 20 mM Tris–HCl, pH 8.0, 100 mM NaCl
and 0.05% NP-40, and 2 times in 20 mM Tris–HCl, 100 mM NaCl, pH 7.5,
buffer. The final pellet was resuspended at a 1:1 ratio in the final wash buffer and
kept at 4 °C until required.
2.6. Protein–protein interaction
For these studies, extracts from platelet or various rat tissues (100 μg
protein) in 1 ml of buffer B (10 mM Na-phosphate, pH 6.8, and 5 mM
MgCl2) was precleared by the addition of 50 μl of GST bead suspension and
incubation for 1 h with rocking at 4 °C. After centrifugation, the supernatant
was collected and incubated with 50 μl of GST-Ral-GDP or GST-cH-Ras-
GDP beads on a rocker for 1 h at 4 °C. At the end of the incubation, beads
were collected by centrifugation and washed three times in buffer B. The final
pellet was resuspended at a 1:1 ratio in buffer B and kept at 4 °C until further
use.
2.7. Partial purification of RIK
We partially purified RIK from two sources: human platelets and rat
testis. Tissue extracts were prepared from 10 units of platelet concentrate or
from 40 g of rat testis as described above. In either case, the supernatant in
buffer A was brought up to 0.2 M in NaCl and loaded onto a Fast Flow Q
Sepharose column. After washing the column with buffer B containing
0.2 M NaCl, bound proteins were eluted using a 0.2–0.5 M NaCl gradient
in the same buffer and 5.0 ml fractions collected. To assay for RIK activity,
20 μl sample from every fraction was added to 1 ml of buffer B containing
20 μl of GST-RalAVal23-GDP bead suspension. The mixture was incubated
on a rocker for 1 h at 4 °C. The beads were collected by centrifugation,
washed 3 times in buffer B, resuspended at a 1:1 ratio in the same buffer
and kept at 4 °C. To detect RIK activity, an aliquot (10 μl) of the
resuspended bead suspension was used for in vitro phosphorylation of GST-
RIP1. Fractions containing the highest RIK activity were pooled, dialysed
against buffer B over-night with two changes and loaded onto a Fast Flow S
Sepharose column. Bound proteins were eluted using a 0–0.4 M NaCl linear
gradient and 2.5 ml fractions collected. After assaying for kinase activity,
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column. The column was washed with buffer B and bound proteins eluted
using 0.2–0.5 M NaCl gradient (2.5 ml/fraction). After assaying for RIK,
fractions with the highest activity were pooled and kept at 4 °C until further
use. Estimation of RIK activity in the pooled fractions at each purification
step was based on the quantity of 32P incorporated during in vitro
phosphorylation of GST-RIP1 by the kinase bound to 20 μl of GST-RalA
bead suspension (1:1) that had been previously incubated with 20 μl sample
from each pool.
2.8. In vitro phosphorylation
In case of substrate specificity studies, 6 μg of the protein was incubated
for 1 h at 37 °C in 30 μl of phosphorylation buffer (50 mM Tris–HCl, pH
7.5, 20 mM MgCl2, 5 mM DTT and 10 μM ATP (0.1 μCi/μl [γ-
32P]ATP))
plus kinase sample. In all other cases, 10 μl of GST-RIP1 bead suspension
was introduced into the phosphorylation mixture and the reaction carried out
for 1 h at 37 °C. The reaction was stopped by the addition of Laemmli's
sample buffer [26] and the proteins separated by SDS-PAGE. After staining
with Coomassie blue, the gel was dried and exposed to an X-ray film. To
quantitate radioactivity associated with the substrate protein, the appropriate
region in the gel was cut out, 5 ml of scintillation cocktail added and
radioactivity determined using Beckman scintillation counter (Model LS
5801).
2.9. Calmodulin affinity chromatography
1 g of rat testis was homogenised in a tissue grinder using 10 ml of
phosphate-buffered saline (PBS: 10 mM Na2HPO4, 1.8 mM KH2PO4, 137 mM
NaCl and 2.6 mM KCl, pH 7.4) containing 0.5% CHAPS and 0.2 mM CaCl2.
After centrifugation at 100,000×g for 1 h at 4 °C, the supernatant was applied to
a calmodulin-agarose column (0.5 ml) pre-equilibrated with PBS containing
0.2 mM CaCl2 (PBS-CaCl2). The column was washed extensively with PBS-
CaCl2. The bound proteins were eluted using PBS-CaCl2 containing 0.1 mg/ml
of peptide corresponding to the C-terminal of either RalA (KRKSLAKRIRERC)
or RalB (KSSKNKKSFKERC) [8] and 0.5 ml fractions were collected. The
fractions were analyzed for the presence of Ral by the overlay binding assay
using [α-32P]GTP and RIK activity was detected by in vitro phosphorylation of
GST-RIP1.
2.10. In-gel renaturation RIK assay
GST-RIP1 was eluted from the glutathione-agarose beads by incubating with
10% SDS (55 °C for 20 min). 0.1 mg/ml of eluted GST-RIP1 was incorporated
into the separating gel. The sample containing the kinase was heated in
Laemmli's sample buffer at 55 °C for 10 min and loaded onto the gel. After
separation of polypeptides using SDS-PAGE, the gel was incubated for 1 h at
room temperature with gentle rocking in a buffer containing 50 mM Tris–HCl,
pH 8.0, and 20% 2-propanol, with 3 changes. The gel was incubated for a further
1 h at room temperature in a buffer containing 50 mM Tris–HCl, pH 8.0, 6 M
guanidine HCl and 5 mM β-mercapto-ethanol. The kinase was allowed to
renature by treating the gel in 50 mM Tris–HCl, pH 8.0, 5 mM β-mercapto-
ethanol and 0.04% NP-40 for 16 h at 4 °C with 3 changes. The gel was
equilibrated in the kinase buffer (50 mM Tris–HCl, pH 7.5, 20 mM MgCl2 and
2 mM DTT) for 1 h at room temperature. The phosphorylation of in-gel GST-
RIP1 by the renatured RIK was carried out in the kinase buffer containing
[γ-32P]ATP (5 μCi/ml) for 1 h at room temperature. After extensive washing in
5% TCA containing 1% Na-pyrophosphate, the gel was stained using
Coomassie blue, destained and dried. To detect regions of phosphorylated
GST-RIP1, the gel was exposed to an X-ray film using an Intensifying screen
(16 h, −70 °C).
2.11. Phosphoamino acid analysis
Phosphoamino acid analysis was performed in the laboratory of Dr. D.
Litchfield (University ofWestern Ontario, London, Ont., Canada) and was based
on the method of Kamps and Sefton [27]. Briefly, 5 μg of GST-RIP1 wasphosphorylated in the presence of 3 μl of partially purified RIK, subjected to
SDS-PAGE separation, and the proteins were transferred onto a PVDF
membrane. The GST-RIP1 band was identified by autoradiography, excised
from the membrane and subjected to HCl hydrolysis at 110 °C for 1 h. The
hydrolyzate was separated by two-dimensional thin layer chromatography. After
staining with ninhydrin, the position of the radioactive spot was compared to
that of the phosphoamino acid standards.
2.12. [α-32P]GTP-overlay binding assay
For the detection of proteins capable of binding [α-32P]GTP on
nitrocellulose blots after SDS-PAGE, the procedure described in [3] was used.
2.13. Determination of protein concentration
Protein concentration in various samples was determined using the Bio-Rad
protein-dye reagent based on the method of Bradford [28]. Standard protein
solution used contained 3% globulin and 5% human albumin.3. Results
3.1. Detection of RIK in human platelets
Subtype specific antibodies were used to immunoprecipi-
tate RalA and RalB from human platelets. Aliquots of RalA,
RalB or non-specific rabbit IgG immunoprecipitates were
probed after SDS-PAGE and blotting using the [α-32P]GTP
overlay binding assay. A protein of molecular mass of
27 kDa that bound [α-32P]GTP on nitrocellulose blots (one
of the characteristics of Ral proteins) was detected in RalA
and RalB but not in the non-specific IgG immunoprecipi-
tates (Fig. 1A). This confirmed that endogenous RalA and
RalB proteins were immunoprecipitated by their respective
antibodies. To detect the presence of kinase activity, RalA,
RalB and IgG immunoprecipitates were used to phosphor-
ylate MBP, histones and casein in vitro. The analysis
revealed the presence of kinase activity with RalA and RalB
immunoprecipitates that preferentially phosphorylated MBP
(Fig. 1B).
The specificity of the Ral-kinase interaction was confirmed
using bacterially expressed recombinant small GTPases. GST-
RalA, GST-RalB and GST-cH-Ras beads incubated with the
platelet extract were used to phosphorylate MBP, histones and
casein in vitro. A kinase with the same substrate specificity as
that co-immunoprecipitated with the endogenous platelet RalA
and RalB was associated with the GST-RalA and GST-RalB
beads but not with the GST-cH-Ras beads (Fig. 2). We have
termed the kinase RIK for, Ral-Interacting Kinase. We found
that GST-RalA, GST-RalB and mutant GST-RalAVal23 bound
RIK with equal efficiency (results not shown). Thus, only GST-
RalA (or GST-RalAVal23 in some cases) was used in further
experiments.
3.2. Substrate specificity of RIK
Although RIK phosphorylated MBP, the identity of the
physiological substrate for this kinase was unknown. We
hypothesized that RIK may phosphorylate protein(s) involved
in the Ral-signalling pathway. Thus, partially purified human
Fig. 2. A kinase from human platelets binds to recombinant RalA and RalB.
200 μl GST-RalA-GDP or GST-RalB-GDP or GST-cH-Ras-GDP bead
suspension (1:1) was incubated with total human platelet extract. The beads
were washed 3 times in wash buffer (20 mM Tris–HCl, pH 8.0, 100 mM NaCl
and 0.05% NP-40) and 2 times in 20 mM Tris–HCl, pH 7.5, buffer. The kinase
activity was measured in vitro using 10 μl of the beads in phosphorylation
reactions using no substrate, 6 μg MBP, 6 μg total histones or 6 μg casein. The
phosphorylated proteins were visualised after SDS-PAGE and autoradiography.
The radioactive bands were excised from the gel and associated radioactivity
was quantitated by scintillation counting. The data are representative of five
independent experiments.
Fig. 1. A kinase from human platelets co-immunoprecipitates with RalA and
RalB. (A) 10 μl of platelet RalA, RalB and non-specific IgG immunoprecipitate
bead suspension (1:1) were heated at 100 °C for 3 min in Laemmli's sample
buffer. Solubilized proteins were separated by SDS-PAGE, transferred onto
nitrocellulose membrane and the blot was probed using [α-32P]GTP-overlay
binding assay. The mobility of prestained standards is indicated on the right. (B)
7 μl of RalA, RalB, or non-specific IgG immunoprecipitate bead suspension
(1:1) were added to the phosphorylation mixture containing 6 μg of MBP, total
histones or casein. The phosphorylated proteins were resolved by SDS-PAGE
and an autoradiograph developed. The radioactive bands were excised from the
gel and associated radioactivity was quantitated by scintillation counting. The
result shown is a representative of at least three separate experiments.
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proteins involved in the Ral-signalling pathway using as
substrates GST-RalA, GST-RalB, GST-cH-Ras and GST-
RIP1. The results showed that there was no significant
phosphorylation of RalA, RalB or cH-Ras (Fig. 3). However,
the ral-interacting protein, RIP1, was found to be an excellent
substrate for RIK (Fig. 3). Thus, in majority of the experiments
GST-RIP1 was used as the substrate for the detection and
characterization of RIK.
3.3. Tissue distribution of RIK
GST-RalAVal23 or GST-cH-Ras coupled to GSH-agarose
beads were incubated with rat tissue extracts and RIK bound
to these beads was used to phosphorylate GST-RIP1 in vitro.
As shown in Fig. 4A, RIK activity was detected in majority
of the rat tissues tested. As measured by the in vitro
phosphorylation of GST-RIP1, testis exhibited the highest
activity of RIK, moderate activities were detected in spleen
and kidney, and lower activities in brain and heart. Liver and
skeletal muscle demonstrated the lowest activity of RIK.Under these conditions, GST-cH-Ras did not bind RIK from
any rat tissue confirming the specificity of Ral–RIK
interaction (Fig. 4A).
3.4. Molecular mass of RIK
We developed an in-gel renaturation assay for RIK as
described in Materials and methods that enabled us to
determine its molecular mass. The kinase was allowed to
renature and phosphorylate GST-RIP1 incorporated in the
separating gel. When GST-RalAVal23 coupled to GSH-agarose
beads and incubated with various rat tissue extracts were
subjected to the in-gel renaturation kinase assay, polypeptides
of ∼36–40 kDa with kinase activity and with varying degrees
of expression in different tissues were observed (Fig. 4B).
The ∼38 kDa band was present with the highest level of
activity in testis (Fig. 4B). Moderate levels of activity of the
36 kDa band were observed in spleen with lower levels
present in liver and kidney (Fig. 4B). The ∼40 kDa band was
most prominent in brain with lower amounts in heart (Fig.
4B). Both the 38- and 40 kDa kinase species were present in
testis (Fig. 4B). In skeletal muscle, the kinase band
corresponding to 38- or 40 kDa was not detected (Fig. 4B).
Fig. 3. Substrate specificity of RIK. 100 μl of the partially purified kinase pool from human platelets was incubated with 50 μl of GST-RalAVal23-GDP bead suspension
(1:1) in 1 ml of buffer B for 1 h at 4 °C. After washing with the same buffer, the beads were resuspended at a 1:1 ratio in buffer B. 10 μl of the bead suspension was used
to phosphorylate MBP, GST-RIP1, GST-RalA, GST-RalB and GST-cH-Ras. The phosphorylated proteins were visualised using SDS-PAGE and autoradiography.
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observed (Fig. 4B). We did not detect kinase bands
corresponding to 36–40 kDa when GST-cH-Ras beads
containing proteins adsorbed from rat testis, brain and
human platelet lysate were analyzed using the in-gel
renaturation assay (Fig. 4B). The 36–40 kDa kinase bands
did not possess any autophosphorylation activity (results not
shown). An ∼50 kDa polypeptide with possible kinase activity
was observed in both the GST-Ral and GST-cH-Ras samples
(Fig. 4B). However, the 50 kDa band was also observed when
GST-Ral and GST-cH-Ras proteins that had not been
incubated with the cell lysate were analyzed using the in-gel
renaturation assay (results not shown). Autophosphorylation of
Ral and cH-Ras proteins has not been reported. Thus, the
50 kDa band probably represents [γ-32P]ATP that was non-Fig. 4. Tissue distribution of RIK. In Panel (A) and Panel (B), 100 μg of total cell lysa
bead suspension. After centrifugation, RIK was adsorbed by incubating the super
described under Materials and methods. In Panel (A), 10 μl of the bead suspension co
phosphorylate GST-RIP1 in vitro. In Panel (B), 20 μl of the bead suspension containin
renaturation kinase assay.specifically associated with GST-Ral and GST-cH-Ras. A band
of ∼66 kDa with kinase activity was observed in both the GST-
Ral and GST-cH-Ras samples that had been incubated with
platelet extract (Fig. 4B). However, only the ∼36–40 kDa
polypeptides with kinase activity towards RIP1 demonstrated
specific interaction with the Ral GTPase.
3.5. Phosphoamino acids analysis
To further characterize RIK, we identified the amino acid
residue(s) phosphorylated in GST-RIP1 or MBP. Phosphory-
lated GST-RIP1 was subjected to acid hydrolysis and
products analyzed using two-dimensional thin layer chroma-
tography. A radioactive band that co-migrated with the
phosphoserine standard was detected (Fig. 5A). Note from various rat tissues and human platelets was precleared using 50 μl of GST
natant with 50 μl of GST-Ral-GDP or GST-cH-Ras-GDP bead suspension as
ntaining RIK adsorbed from various rat tissues and human platelets was used to
g RIK from various rat tissues and human platelets was analyzed using the in-gel
Fig. 5. Phosphoamino acid analysis. RIK partially purified from human platelets
was used to phosphorylate (A) GST-RIP1 or (B) MBP. After SDS-PAGE
separation, the proteins were transferred onto a PVDF membrane. The
radioactive GST-RIP1 band was identified by autoradiography, excised from
the membrane and the phosphoamino acid analysis was performed as described
in Materials and methods. Abbreviations used: o, origin; php, partial hydrolysis
products; PY, phosphotyrosine; PT, phosphothreonine; PS, phosphoserine.
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nine or phosphotyrosine standards. Similar results were
obtained when phosphorylated MBP was analyzed (Fig. 5B).Fig. 6. Binding of RIK to Ral is guanine nucleotide-independent. GST-RalAVal23 im
(A), the GTP or GDP loaded RalAwas cleaved from GST using thrombin and incub
RRBD was eluted using Laemmli's sample buffer and analyzed by SDS-PAGE and w
GTP and GDP sample (input) is also shown. In Panel (B), 20 μl of the various forms
1 ml of buffer B was incubated for 1 h at 4 °C on a rocker. After washing in buffer B,
20 μl of the various forms of the bead suspension plus 20 μl of partially purified rat
washing in buffer B, 10 μl of the bead suspension was used to phosphorylate GST-3.6. Nucleotide dependency of the interaction between Ral and
RIK
We examined if the nucleotide state of the Ral protein
altered its interaction with RIK. Guanine nucleotide-free
GST-RalAVal23 was purified from bacteria in a buffer
containing EDTA. Immobilised GST-RalAVal23 on GSH-
agarose beads was loaded with GTP, GDP or left in the
nucleotide-free state. The results confirmed that RalA was
loaded with GTP as higher amount of RalA was detected in
the sample incubated with GTP compared to the sample
incubated with GDP (Fig. 6A). The beads were incubated
with partially purified RIK from human platelets (Fig. 6B) or
rat testis (Fig. 6C) and used to phosphorylate GST-RIP1. As
shown, there was no difference in the kinase activity
associated with GTP-, GDP-, or nucleotide-free RalA (Fig.
6B and C).
3.7. Evidence for in vivo interaction between Ral and RIK
Recently, it has been shown that RalA interacts with
calmodulin in a Ca2+-dependent manner through its C-
terminus [23]. We employed calmodulin affinity chromato-
graphy to demonstrate the existence of Ral–RIK complex in
vivo. Thus, rat testis lysate was passed through an
calmodulin-agarose affinity column. The bound proteins
were eluted using a 13 amino acid peptide corresponding to
the C-terminus of RalA, KRKSLAKRIRERC (pep-A) [8].
This peptide overlaps by 10 residues the 18 amino acid
sequence, SKEKNGKKKRKSLAKRIR, that has been identi-
fied as the putative calmodulin-binding domain in RalA [23].mobilised on beads was loaded with GTP, GDP or left nucleotide-free. In Panel
ated with GSH-agarose beads containing GST-RRBD. The RalA bound to GST-
estern blotting using antibody against RalA. The amount of RalA in the starting
of bead suspension plus 20 μl aliquot of partially purified human platelet RIK in
10 μl of the bead suspension was used to phosphorylate GST-RIP1. In Panel (C),
testis RIK in 1 ml of buffer B was incubated for 1 h at 4 °C on a rocker. After
RIP1. The proteins were analyzed using SDS-PAGE and autoradiography.
Fig. 8. Phosphorylation of RIP1 by RIK is highly specific. 2 μl of RIK partially
purified from rat testis, ∼1 μg of GST-p38MAPK and ∼0.5 μg of the catalytic
subunit of PKAwere used to phosphorylate: GST-RIP1 (full length), GST-ATF2
(a.a. 1–109), GST-c-Jun (a.a. 1–79) or GST-Rb (a.a. 769–921) as indicated. The
truncated versions of GST-ATF2, GST-c-Jun and GST-Rb used contained the
respective phosphorylation sites. In the lanes containing products of GST-
p38MAPK phosphorylation, a strong band of ∼60 kDa (indicated by an
arrowhead) was due to autophosphorylation of the recombinant GST-
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terminus of RalB, KSSKNKKSFKERC (pep-B) [8], was used
as the negative control since it is distinct from the
calmodulin-binding sequence identified in RalA [23].
We used [α-32P]GTP overlay binding assay and phosphor-
ylation of GST-RIP1 to monitor the presence of Ral and RIK
respectively in fractions from the calmodulin affinity column.
Results demonstrated that Ral was eluted by pep-A (Fig. 7,
panel A, fractions 4–7). However, pep-B did not result in the
elution of Ral protein (Fig. 7, panel B, fractions 2–7).
Analysis for the presence of RIK demonstrated that the kinase
eluted from the calmodulin-agarose column in the same
fractions as Ral and this occurred only when pep-A was used
for the elution (Fig. 7, panel C, fractions 4–7) and not when
pep-B was used for elution (Fig. 7, panel D, fractions 2–7).
No RIK activity was detected in fractions where there was no
Ral protein present (Fig. 7, compare panel A and C versus
panel B and D). These data provide additional support for our
conclusion that endogenous Ral protein exists in a complex
with RIK.Fig. 7. Endogenous Ral associates with RIK in vivo. Rat testis lysate was passed
through a calmodulin-agarose column. Bound proteins were eluted using
peptides corresponding to the C-termini of RalA (pep-A) or RalB (pep-B) as
described under Materials and methods. (A) 40 μl of the fractions eluted with
pep-A or pep-B (B) were separated by SDS-PAGE and transferred onto
nitrocellulose membrane. The blot was subjected to [α-32P]GTP-overlay
binding assay and an autoradiograph developed. The mobility of prestained
marker proteins is indicated on the right. 13 μl of the fractions eluted with pep-A
(C) or pep-B (D) were used to phosphorylate GST-RIP1 in vitro as described
under Materials and methods and the proteins analyzed using SDS-PAGE and
autoradiography. The value underneath the lane refers to the fraction number
assayed.
p38MAPK. Autophosphorylation of the catalytic subunit of PKA (∼45 kDa)
was observed in the lane containing products of this reaction.3.8. Identity of RIK
To investigate the possible relationship between RIK and
other known kinases, we used specific substrates for some of
the serine/threonine kinases in in vitro phosphorylation assays.
RIK did not phosphorylate ATF2 (a substrate for p38MAPK),
Jun (a substrate for Jun-kinase) or retinoblastoma protein (Rb,
a substrate for several CDKs) (Fig. 8). Therefore, out of all the
substrates tested, MBP, which is a non-specific substrate for
many kinases, and RIP1, were the only proteins phosphory-
lated by RIK. We also examined the ability of recombinant
p38MAPK and the catalytic subunit of PKA to phosphorylate
GST-RIP1. Results demonstrated that recombinant p38MAPK
phosphorylated GST-ATF2 and GST-Rb (this result was
unexpected) but it did not phosphorylate GST-c-Jun or GST-
RIP1 (Fig. 8). A band of ∼60 kDa present in the p38MAPK
lanes (Fig. 8, indicated by an arrowhead on the right) was due
to the autophosphorylation of recombinant GST-p38MAPK.
PKA also failed to phosphorylate GST-RIP1 (Fig. 8). The only
band observed in this lane represented autophosphorylation of
PKA. This has led us to the conclusion that RIK is a highly
specific kinase for RIP1. Additional support for this has also
come from the observation that, in-gel renaturation assay
indicated a limited number of protein kinases in total rat testis
lysate that are capable of phosphorylating RIP1. Some of the
minor bands seen in the autoradiograph likely represent
autophosphorylation of protein kinases present in the starting
material rather than kinases that are able to phosphorylate
RIP1.
4. Discussion
In the present study we have demonstrated that the small
GTPase Ral specifically interacts with a serine protein kinase
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conclusion is based on the results of immunoprecipitation of
endogenous Ral–RIK complex as well as in vitro protein–
protein interaction studies using recombinant GTPases. In
addition, Ral and RIK co-eluted from the calmodulin affinity
column upon washing of the column with a 13 residue peptide
(KRKSLAKRIRERC) that overlaps the calmodulin-binding
domain of RalA. The calmodulin binding domain of RalA has
recently been identified as a stretch of 18 amino acids
(SKEKNGKKKRKSLAKRIR) at the C-terminal of this GTP-
ase [23]. Although this sequence has little homology at the
primary level with the model calmodulin binding domain
(LKWKKLLKLLKKLLKKLLKLG) [29], the RalA C-term-
inal region does meet the minimum requirements of a
calmodulin binding motif [23,29]. The RalB protein which
also binds calmodulin [24] does not contain the RalA-like
calmodulin binding domain. Thus, a C-terminal RalB peptide
(KSSKNKKSFKERC) failed to elute either Ral or RIK from
the calmodulin affinity column. The fact that RalB which does
not contain the calmodulin binding domain identified in RalA
was able to bind the kinase confirms that Ral and RIK interact
directly with each other and, that this association is inde-
pendent of calmodulin.
The interaction between Ral and RIK was found to be
independent of the guanine nucleotide status of the GTPase. It is
generally believed that only the activated GTP-bound form of
the small GTPase can interact with their downstream target
proteins including, protein kinases. However, examples of
specific interactions between cellular kinases and small
GTPases that are independent of guanine nucleotides are
known. For instance, it has been documented that PRK2, a
serine/threonine kinase, binds equally efficiently to RhoA
regardless of whether the GTPase is in the GTP- or GDP-bound
state [30]. Rac1 GTPase has been shown to specifically interact
with phosphatidylinositol-4-phosphate 5-kinase and diacylgly-
cerol kinase independently of its guanine nucleotide status
[31–33]. Calmodulin also appears to bind RalA and RalB in a
guanine nucleotide independent manner [23,24] as is the
interaction between Ral-PLD1 [20] and Ral-PLCδ1 [25].
Similarly, Rin, a neuron specific small GTPase, has also been
shown to bind calmodulin in a guanine nucleotide indepen-
dent mode [34]. In addition, Cdc and Rac1 are shown to bind
specifically with a RasGAP termed, IQGAP2, in a guanine
nucleotide independent fashion [35]. Our results along with
those in the literature suggest that small GTPases are able to
specifically interact with their partner proteins in both a GTP-
dependent and -independent fashion. This suggests a model
for protein–protein interaction in which some cellular protein
(s) are constitutively associated with their partner GTPase
while others will go on or off depending on the activation
status of the GTPase. The Ral GTPase fits this model and that
both types of protein–protein interactions play a role in the
Ral signalling pathway.
The substrate specificity studies demonstrated that out of
all the proteins tested, RIK preferentially phosphorylated
RIP1, a Ral-interacting protein, that acts as GTPase
activating protein (GAP) for Cdc42 and Rac1 [18,19]. Thishigh degree of substrate specificity would suggest that RIP1
is potentially the physiological substrate for RIK. The role of
RIP1 phosphorylation on its function is unknown at the
present time. However, it has been shown that activation of
membrane-bound Ral recruits RIP1 from the cytosol to the
membrane [36]. Based on our observation that RIP1 is a
specific substrate for RIK, association of Ral with RIK
would suggest a role for this kinase in the regulation of
Cdc42/Rac1-dependent signalling cascades through the phos-
phorylation of RIP1. One can propose a model in which
activation of Ral results in the recruitment of RIP1 into the
proximity of Ral–RIK complex and the subsequent phos-
phorylation of RIP1. The phosphorylation of RIP1 by RIK
may alter its properties (e.g. GAP activity, ability to interact
with Cdc42/Rac1 or RIP1-interacting protein, Reps1/POB1)
or cause its translocation back to the cytosol. The answers to
these questions are not known at the present time.
The initial characterization of RIK demonstrated that this is a
serine kinase of molecular mass of ∼36–40 kDa. The tissue
distribution of RIK resembled that of Ral [2,3] with testis
containing the highest and skeletal muscle the lowest activity.
The in-gel renaturation assay demonstrated that the different
kinase bands were not expressed in all rat tissues. The reason for
heterogeneity of expression and the presence of various kinase
bands is not clear. The presence of 36–40 kDa bands may
represent isoforms or the lower bands can be proteolytic
fragment of the 40 kDa protein. However, inclusion of various
proteolytic inhibitors in experiments did not abolish the lower
bands suggesting that they are not proteolytic fragment (data not
shown).
The identity of RIK has not been positively established
due to the low amounts of protein obtained after purification.
However, some of the known kinases with specificity and
molecular mass similar to that of RIK were ruled out as
candidates. Thus, RIK is not one of the known MAPKs
(ERK-1, ERK-2, p38MAPK or Jun-kinase), or related to
CDKs that contain the PSTAIRE motif or capable of
phosphorylating Rb protein. Biochemical properties also
ruled out RIK as one of the Ca2+/calmodulin dependent
protein kinases. In addition, RIP1 was not phosphorylated by
recombinant p38MAPK or the catalytic subunit of cAMP
dependent protein kinase. From these data one can conclude
that RIK probably represents a novel serine kinase whose
identity remains to be established.
The function of Ral–RIK interaction in the cell is not known.
But Ral is believed to play a role in agonist regulated secretion
since this GTPase has been shown to be associated with the
platelet storage granules and with neuronal synaptic vesicles
[5–7]. In regulated secretion, cytoskeletal reorganization is a
requisite and this is regulated by Cdc42 and Rac1 [37]. The
Ral–RIK interaction can play a role in this process since RIP1
acts as a GTPase for Cdc42 and Rac1 [18,19], and thus can
influence the duration that these GTPases are in their activated
state. The data presented in this paper provide further support
for a link between the Ral and Cdc42/Rac1 signalling pathways.
According to our model RIP1 recruited to Ral upon its activation
will be phosphorylated by RIK that is constitutively associated
956 O. Jilkina, R.P. Bhullar / Biochimica et Biophysica Acta 1763 (2006) 948–957with Ral. The phosphorylation may alter RIP1 activity and thus
enhance/decrease its action towards Cdc42 and Rac1 function.
The identification of RIK and functional effect of RIP1
phosphorylation will help in delineating the role of this
interaction in cellular pathways in particular, the Cdc42 and
Rac1 regulated pathways.
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